NovaBone Products Pvt. Ltd. was established in 2012 in Bangalore India as a branch office for the parent company NovaBone Products LLC as a sales and marketing office to support the growing user base in the region. Since 2016, partnerships with Osteogenics, Collagen Matrix, BiLumix, Dowell & Ace Surgical has strengthened the product portfolio. In 2018 NovaBone India signed an exclusive distribution agreement with Zimmer Biomet Dental to distribute their product portfolio in India.
The Indian entity evolved into a specialty surgical solutions company and emerged as a marketplace leader with a uniquely “American” product portfolio and exclusive partnerships with global brand leaders. With a hybrid network of distributors and direct sales reps, the Indian entity has a good network to ensure product support and availability.
Headquartered in Jacksonville, Florida, NovaBone has operations and R&D facility in Alachua, FL. In March 2014, NovaBone relocated into a 30,000 sq. ft. building in Alachua, Florida more than doubling the previous footprint and combining the company’s manufacturing and R&D operations under one roof. NovaBone has developed numerous formulations and delivery systems of its patented, bioactive technology platform that results in accelerated bone growth. The exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system for over 15 years and used in over a million clinical applications with unparalleled success validating the safety and efficacy of the technology.
Zimmer Dental and Biomet 3i joined forces to become the Zimmer Biomet dental division with 60+ years of combined experience in the dental implant industry. The portfolio is robust with surgical, restorative, regenerative, and digital dentistry solutions. A collection of 319 (combined) patents and 161 pending patents and over 200+ publications with long term follow-up data reinforces the brand and its unmatched offerings.
Founded in 1996, with a mission to develop dental bone grafting products, Osteogenics Biomedical is a global leader in the development of innovative dental bone grafting products. Osteogenics Biomedical's focus is on alveolar ridge preservation, guided bone regeneration, and implant site development. Osteogenics’ regenerative portfolio includes the complete line of non-resorbable Cytoplast Barrier Membranes, Cytoplast Sutures and the Pro-Fix™ Precision Fixation System.
Collagen Matrix Inc. was founded in 1997, since then the company has launched over 50 medical devices for five business units – Dental, Spine, Orthopedic, Dural Repair and Nerve Repair. The company has two facilities in New Jersey, USA with the Corporate Headquarters located in Oakland, NJ. The evolution of the company’s leadership, proprietary technologies, design capabilities, manufacturing expertise and product portfolio has established a solid foundation for continued growth as a market leader in regenerative products.